MeiraGTx Holdings (MGTX) Change in Account Payables (2017 - 2025)
MeiraGTx Holdings' (MGTX) quarterly Change in Account Payables came in at -$10.0 million in Q4 2025, down 202.83% YoY from $9.7 million in Q4 2024, and down 1742.08% on a QoQ basis from $606000.0 in Q3 2025.
Analysis
MeiraGTx Holdings (MGTX) Change in Account Payables (2017 - 2025) Analysis & Trends
MeiraGTx Holdings (MGTX) has 9 years of Change in Account Payables data on file, last reported at -$10.0 million in Q4 2025.
- Quarterly Change in Account Payables fell 202.83% year-over-year to -$10.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$12.3 million (down 214.67% YoY) and the FY2025 annual result came in at -$12.3 million, down 214.67% from the prior year.
- Change in Account Payables fell to -$10.0 million in Q4 2025, from $606000.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $14.6 million in Q1 2023 to a low of -$10.0 million in Q4 2025.
- A 5-year average of $891950.0 and a median of $539000.0 in 2024 frame the typical range for Change in Account Payables.
- Annual changes were most pronounced in 2021 — Change in Account Payables jumped 770.88% — and 2023, when it slumped 256.01%.
- Tracing MGTX's Change in Account Payables over 5 years: stood at $9.4 million in 2021, then slumped by 151.76% to -$4.9 million in 2022, then soared by 37.37% to -$3.1 million in 2023, then fell by 7.28% to -$3.3 million in 2024, then tumbled by 202.83% to -$10.0 million in 2025.
- The last three Change in Account Payables figures came in at -$10.0 million (Q4 2025), $606000.0 (Q3 2025), and $93000.0 (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -8.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 5.03 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 37.53 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | MeiraGTx Holdings | 1.27 Bn | 1.13 Bn | 315.67 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -9.95 Mn |
| Sep 30, 2025 | 606,000.00 |
| Jun 30, 2025 | 93,000.00 |
| Mar 31, 2025 | -3.06 Mn |
| Dec 31, 2024 | -3.29 Mn |
| Sep 30, 2024 | 8.35 Mn |
| Jun 30, 2024 | 472,000.00 |
| Mar 31, 2024 | 5.20 Mn |
| Dec 31, 2023 | -3.06 Mn |
| Sep 30, 2023 | -7.68 Mn |
| Jun 30, 2023 | -1.57 Mn |
| Mar 31, 2023 | 14.64 Mn |
| Dec 31, 2022 | -4.89 Mn |
| Sep 30, 2022 | 4.92 Mn |
| Jun 30, 2022 | -903,000.00 |
| Mar 31, 2022 | 4.61 Mn |
| Dec 31, 2021 | 9.45 Mn |
| Sep 30, 2021 | 1.38 Mn |
| Jun 30, 2021 | 926,000.00 |
| Mar 31, 2021 | 1.59 Mn |